Medicare Enrolled

Dr. David Schwartzwald, M.D.

Urology Physician · Boca Raton, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1601 CLINT MOORE RD, Boca Raton, FL 33487
5619390700
In practice since 2006 (19 years)
NPI: 1104878594 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Schwartzwald from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schwartzwald? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Schwartzwald

Dr. David Schwartzwald is an urology physician in Boca Raton, FL, with 19 years in practice. Based on federal Medicare data, Dr. Schwartzwald performed 102,656 Medicare services across 7,598 unique beneficiaries.

Between the years covered by Open Payments, Dr. Schwartzwald received a total of $6,529 from 21 pharmaceutical and/or device companies across 90 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Schwartzwald is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 1% volume in FL$ $6,529 industry payments

Medicare Practice Summary

Medicare Utilization ↗
102,656
Medicare services
Top 1% in FL for urology physician
7,598
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,403 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Testosterone injection86,361$0$0
BCG treatment for bladder cancer3,400$2$8
Automated urinalysis3,308$2$9
Bladder ultrasound after voiding2,812$8$33
Office visit, established patient (20-29 min)1,711$69$280
Office visit, established patient (30-39 min)1,597$95$396
Blood draw (venipuncture)1,180$8$9
Drug injection, under skin or into muscle568$10$43
New patient office visit (45-59 min)538$123$520
Diagnostic exam of bladder and urethra using an endoscope166$184$747
Leuprolide acetate (for depot suspension), 7.5 mg165$135$565
Ultrasound scan of pelvic region through rectum146$103$614
Hospital follow-up visit, moderate complexity88$65$248
Instillation of anti-cancer drug into bladder77$70$275
Simple insertion of temporary bladder tube76$47$191
Initial hospital admission, moderate complexity75$107$410
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle56$27$104
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and52$42$161
Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm47$632$2,426
Electronic assessment of bladder emptying31$6$45
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings29$34$200
Injection procedure to cause erection23$65$286
Biopsy of prostate gland21$108$412
Ultrasonic guidance for needle placement21$25$152
Crushing of stone of ureter with insertion of stent using an endoscope18$343$1,656
Waterjet destruction of prostrate accessed through the urethra17$575$2,371
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies17$312$1,198
Insertion of device into abdomen with pressure and urine flow rate study17$155$593
Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope14$605$2,310
Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm13$224$910
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional12$19$71
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,529
Total received (2018-2024)
Avg $933/year across 7 years
Top 33% in FL for urology physician
21
Companies
90
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,783 (88.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$746 (11.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$458
2023
$1,002
2022
$868
2021
$259
2020
$98
2019
$1,782
2018
$2,062

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
NeoTract Inc.
$2,977
Medtronic, Inc.
$688
Coloplast Corp
$629
PROCEPT BioRobotics Corporation
$612
Boston Scientific Corporation
$260
Astellas Pharma US Inc
$229
Olympus America Inc.
$210
Terumo Medical Corporation
$142
BOSTON SCIENTIFIC CORPORATION
$130
Janssen Biotech, Inc.
$125
AstraZeneca Pharmaceuticals LP
$125
Endo Pharmaceuticals Inc.
$99
Laborie Medical Technologies Corp.
$79
Augmenix, Inc.
$75
Ferring Pharmaceuticals Inc.
$54
Teleflex LLC
$24
Verity Pharmaceuticals Inc.
$20
Antares Pharma, Inc.
$16
PFIZER INC.
$15
Innovation Technologies Inc
$13
United Service Solutions LLC
$8
Top 3 companies account for 65.8% of total payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS · AMS 700 CXR RTE KIT · AMS 700 CXR RTE Kit · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · ERLEADA · Erleada · GENERAL ERECTILE DYSFUNCTION · GLIDESHEATH SLENDER · INTERSTIM · Irrisept · LYNPARZA · MYRBETRIQ · NOCDURNA · Rezum Generator · SPEEDICATH · STEALTHSTATION S8 PLATFORM · Soltive · SpaceOAR · TITAN · Titan · Trelstar · UROLIFT · UroLift · XIAFLEX · XTANDI · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $6 per 100 Medicare services performed
Looking for a urology physician in Boca Raton?
Compare urology physicians in the Boca Raton area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
104
Per 100K population
6.9
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
4.1 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Schwartzwald is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Schwartzwald experienced with testosterone injection?
Based on Medicare claims data, Dr. Schwartzwald performed 86,361 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schwartzwald receive payments from pharmaceutical companies?
Yes. Dr. Schwartzwald received a total of $6,529 from 21 companies across 90 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schwartzwald's costs compare to other urology physicians in Boca Raton?
Dr. Schwartzwald's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schwartzwald) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →